Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07105007 · ClinicalTrials.gov registry record · NA

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV

A NA study of Heart Failure and HIV, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT07105007 is a NA study of Heart Failure and HIV that is actively recruiting participants, run by University of Washington. The registered enrollment target is 30 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07105007, a NA study of Heart Failure and HIV, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

Heart failure (HF) is a growing health and economic burden around the globe, and it remains a leading cause of morbidity and mortality among the general population. HIV is recognized as an independent risk factor for HF, due to direct and indirect effects. Furthermore, people living with HIV (PLWH) now have an increased life expectancy due to the evolution and widespread use of antiretroviral therapy (ART), leading to a rising burden of cardiovascular disease (CVD) and HF among this population. Yet, the provision of appropriate guideline-recommended cardiovascular care is lower in PLWH compared to the general population, and there are no studies testing HF prevention interventions focused on PLWH. Current guidelines for HF management highlight the importance of a healthy lifestyle in preventing and treating HF. Among PLWH, tailored, innovative, and sustainable exercise delivery models are necessary to overcome barriers and increase physical activity (PA) adherence in this population. Building on the research team's prior mixed methods work and research expertise on exercise trials for PLWH, the investigators propose the Hybrid Exercise Intervention for Cardiovascular Health of People living with HIV (HEICA-HIV). HEICA-HIV is a novel multi-component 8-week intervention that will simultaneously deliver a supervised center-based (once a week) and a tailored home-based (twice a week) exercise intervention, together with exercise and cardiovascular health education. It will also involve behavioral coaching and mobile health support. The investigators evidence suggests that, by providing weekly exercise supervision together with a home-based prescription, the investigators can overcome difficulties associated with home-based programs (e.g., less intensive exercise training, less social support, and less face-to-face monitoring), and still observe the augmented health benefits obtained from supervised programs. Additionally, by requiring less time at the training center,

Conditions Studied

Interventions

  • BEHAVIORAL Exercise Intervention
  • BEHAVIORAL Tailored Education sessions
  • BEHAVIORAL Behavioral coaching
  • BEHAVIORAL Mobile health support
  • BEHAVIORAL General education

Study Locations (2)

Washington

  • University of Washington - Seattle

Paraná

  • Londrina State University - Londrina

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-08-15
Est. Completion 2026-07-01
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT07105007

The ClinicalTrials.gov registry entry for NCT07105007 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 5 interventions - of which Exercise Intervention is the first listed.

NCT07105007 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Washington, Paraná.

Frequently Asked Questions

What is clinical trial NCT07105007 about?

NCT07105007 is a clinical study titled "Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV". Heart failure (HF) is a growing health and economic burden around the globe, and it remains a leading cause of morbidity and mortality among the general population. HIV is recognized as an independent risk factor for HF, due to direct and indirect effects. Furthermore, people living with HIV (PLWH) ...

What is the current status of trial NCT07105007?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-15. Estimated completion is 2026-07-01.

What conditions does trial NCT07105007 study?

This clinical trial studies the following conditions: Heart Failure, HIV.

What interventions are being tested in trial NCT07105007?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL), Tailored Education sessions (BEHAVIORAL), Behavioral coaching (BEHAVIORAL), Mobile health support (BEHAVIORAL), General education (BEHAVIORAL).

Who is sponsoring clinical trial NCT07105007?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07105007 being conducted?

This trial has 2 study locations across Washington, Paraná. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.